🇺🇸 FDA
Patent

US 10391175

BET bromodomain inhibitors and therapeutic methods using the same

granted A61KA61K45/06A61P

Quick answer

US patent 10391175 (BET bromodomain inhibitors and therapeutic methods using the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K45/06, A61P, A61P1/02, A61P1/04